Social networks
296 2,391Activities
Technologies
Entity types
Location
5 Av. du Grand Sablon, 38700 La Tronche, France
La Tronche
France
Employees
Scale: 2-10
Estimated: 7
SIREN
529396608Engaged corporates
12Added in Motherbase
5 years, 7 months agoCell-free systems expert ! The futures of protein !
Best chance for your protein projects !
A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. Cell-free expression is a field of expertise that is growing constantly. However, the future offers so much more. And Synthelis is both proud of the role it is playing in this industrial revolution and committed to developing its research to bring this fruit to bear in what will be the advent of synthetic biology.
protein identification, protein characterization, protein production, protein delivery, cell-free, antibody development, vaccine development, screening, display technology, in vitro diagnostics, structural biology, protein in detergent, protein in proteoliposome, Synthetic biology, Protein purification, Therapeutic protein, Biologic, Antigen, Cytotoxic protein, and nanodisc
Cell-free systems expert ! The futures of protein !
Best chance for your protein projects !
A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. Cell-free expression is a field of expertise that is growing constantly. However, the future offers so much more. And Synthelis is both proud of the role it is playing in this industrial revolution and committed to developing its research to bring this fruit to bear in what will be the advent of synthetic biology.
Synthelis est l’expert français en systèmes « Cell-Free ». Notre technologie propriétaire permet de développer et produire des produits de santé innovants.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Not capitalistic Not partnership Event 16 Apr 2024 | | |
Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 8 Jul 2021 11 Apr 2024 | | |
Grenoble-Alpes Métropole Government Administration, French metropolis | Grenoble-Alpes Métropole Government Administration, French metropolis | Other 11 Jul 2023 | | |
CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 5 Jul 2023 | | |
CIC Bank, Banking | CIC Bank, Banking | Other 1 May 2023 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 31 Mar 2023 | | |
Technopôle de l'environnement de l'Arbois Government Administration | Technopôle de l'environnement de l'Arbois Government Administration | Other 10 Mar 2023 | | |
INRAE Research, Research Services | INRAE Research, Research Services | Other 25 Oct 2022 | | |
NASA - National Aeronautics and Space Administration Research, Aviation and Aerospace Component Manufacturing | NASA - National Aeronautics and Space Administration Research, Aviation and Aerospace Component Manufacturing | Other 14 Oct 2022 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 8 Oct 2022 | |